AW
PFE icon

Alaethes Wealth’s Pfizer PFE Stock Holding History

Alaethes Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,685
Closed -$1.13M – 115
2023
Q2 		$1.13M Buy
30,685
+935
+3% +$36.4K 0.62% 67
2023
Q1 		$1.21M Buy
29,750
+3,001
+11% +$130K 0.71% 57
2022
Q4 		$1.37M Sell
26,749
-123
-0.5% -$5.9K 0.94% 40
2022
Q3 		$1.18M Buy
26,872
+1,121
+4% +$54.5K 0.86% 38
2022
Q2 		$1.35M Buy
25,751
+1,626
+7% +$82.9K 1% 28
2022
Q1 		$1.25M Sell
24,125
-1,673
-6% -$86.8K 0.79% 47
2021
Q4 		$1.52M Buy
25,798
+3,508
+16% +$174K 0.96% 30
2021
Q3 		$959K Buy
22,290
+377
+2% +$16.7K 0.7% 56
2021
Q2 		$858K Sell
21,913
-667
-3% -$25.9K 0.66% 64
2021
Q1 		$818K Buy
+22,580
New +$802K 0.76% 53

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alaethes Wealth's PFE Position: Q3 2023 in Review

Alaethes Wealth sold out of Pfizer (PFE) in Q3 2023, closing a stake of 30,685 shares — an estimated $1.13M sold.

Alaethes Wealth first reported a position in PFE in Q1 2021 and held it in 10 quarters. The position peaked at $1.52M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Alaethes Wealth reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Alaethes Wealth sold 30,685 Pfizer shares in Q3 2023, an estimated $1.13M.
  • Alaethes Wealth first reported a position in Pfizer in Q1 2021 and held it in 10 quarters.
  • Alaethes Wealth's Pfizer position peaked at $1.52M in Q4 2021.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Alaethes Wealth's 13F filing for Q3 2023, filed 13 Nov 2023.